MetLife Investment Management’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,118
| Closed | -$248K | – | 2875 |
|
|
2024
Q2 | $248K | Buy |
17,118
+2,723
| +19% | +$39.4K | ﹤0.01% | 2116 |
|
|
2024
Q1 | $239K | Hold |
14,395
| – | – | ﹤0.01% | 2092 |
|
|
2023
Q4 | $231K | Buy |
14,395
+2,830
| +24% | +$45.4K | ﹤0.01% | 2161 |
|
|
2023
Q3 | $156K | Hold |
11,565
| – | – | ﹤0.01% | 2338 |
|
|
2023
Q2 | $199K | Buy |
11,565
+2,860
| +33% | +$49.2K | ﹤0.01% | 2282 |
|
|
2023
Q1 | $144K | Buy |
8,705
+667
| +8% | +$11K | ﹤0.01% | 2397 |
|
|
2022
Q4 | $134K | Hold |
8,038
| – | – | ﹤0.01% | 2469 |
|
|
2022
Q3 | $137K | Buy |
+8,038
| New | +$137K | ﹤0.01% | 2516 |
|